4.7 Review

EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Innovations in CRISPR-Based Therapies

Gokul Kesavan

Summary: Gene and cell therapies, especially the application of CRISPR technology, have made significant progress in recent years. In vivo CRISPR therapy is mainly used for the treatment of eye and liver diseases, while ex vivo therapy has the advantage of characterizing gene edits before infusion and restricting off-target effects. The article also discusses the safety, affordability, and feasibility of CRISPR therapies.

MOLECULAR BIOTECHNOLOGY (2023)

Review Biochemistry & Molecular Biology

Fli1 and Tissue Fibrosis in Various Diseases

Elena V. Mikhailova et al.

Summary: Initially described as a factor of virally-induced leukemias, Fli1 has been found to play important roles in normal hematopoiesis, vasculogenesis, and immune response. However, abnormal expression of Fli1 is associated with various diseases of different origins, including cancer and fibrotic disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Chemistry, Medicinal

Recent Advances on Small-Molecule Bromodomain-Containing Histone Acetyltransferase Inhibitors

Mingxia Liu et al.

Summary: In recent years, extensive research has been carried out on the molecular mechanisms and inhibitors targeting bromodomains (BRDs) and extra-terminal (BET) family proteins. Non-BET BRDs are gaining attention as a research hot spot. BRDs are abundant in histone acetyltransferase (HAT)-associated activating transcription factors, and BRD-containing HATs have been associated with cancer, inflammation, and viral replication. The development of BRD-containing HATs as chemical probes is valuable for understanding the specific biological roles of BRDs in diseases and drug discovery. Different types of BRD-containing HATs, including CBP/P300, PCAF/GCN5, and TAF1, are discussed in terms of their structures, functions, and small-molecule inhibitors. Furthermore, the progress in BRD inhibitors/chemical probes and proteolysis targeting chimeras regarding drug design, biological activity, and disease application is summarized. These findings provide insights into the development of BRD inhibitors as potential drug candidates for various diseases.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Pharmacology & Pharmacy

Twist1-YY1-p300 complex promotes the malignant progression of HCC through activation of miR-9 by forming phase-separated condensates at super-enhancers and relieved by metformin

Jing Meng et al.

Summary: This study reveals the association between miR-9 and poor prognosis in hepatocellular carcinoma (HCC) patients. It demonstrates that the Twist1 and YY1 proteins form a complex with p300 to activate the expression of miR-9 and promote the malignant progression of HCC through stimulating migration and invasion of HCC cells. The disruption of this complex by metformin (Met) reduces miR-9 expression and inhibits the malignant progression of HCC.

PHARMACOLOGICAL RESEARCH (2023)

Article Multidisciplinary Sciences

Lactate promotes endothelial-to-mesenchymal transition via Snail1 lactylation after myocardial infarction

Min Fan et al.

Summary: High levels of lactate are associated with poor prognosis and mortality in patients with heart attack. Lactate promotes cardiac fibrosis and exacerbates cardiac dysfunction by inducing EndoMT, which is mediated by the TGF-β/Smad2 pathway.

SCIENCE ADVANCES (2023)

Article Chemistry, Medicinal

Metformin Induces Apoptosis in Human Pancreatic Cancer (PC) Cells Accompanied by Changes in the Levels of Histone Acetyltransferases (Particularly, p300/CBP-Associated Factor (PCAF) Protein Levels)

Izabela Szymczak-Pajor et al.

Summary: Accumulating evidence suggests that metformin has anticancer properties by inducing apoptosis and inhibiting the growth and proliferation of cancer cells. However, its effect on histone acetylation status remains unclear. Therefore, this study aimed to evaluate the impact of metformin on HATs and HDACs in human pancreatic cancer cell lines.

PHARMACEUTICALS (2023)

Article Biochemistry & Molecular Biology

The Role of IL-13 and IL-4 in Adipose Tissue Fibrosis

Lilli Arndt et al.

Summary: White adipose tissue fibrosis is strongly associated with inflammation and dysfunction due to obesity. IL-13 and IL-4 have been identified as critical mediators in fibrotic diseases, but their role in WAT fibrosis is still unclear.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cardiac & Cardiovascular Systems

HEART-ENRICHED LONG NONCODING RNA NPPA-AS1 REGULATES PATHOLOGICAL CARDIAC HYPERTROPHY BY INITIATING A EP300-GATA4 AXIS

Zeng Chunyu

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Article Medical Laboratory Technology

SIK2 protects against renal tubular injury and the progression of diabetic kidney disease

Bingyao Liu et al.

Summary: Reduced expression of SIK2 contributes to renal tubular injury and fibrosis in diabetic kidney disease (DKD). SIK2 overexpression reduces ER stress-mediated tubular epithelial apoptosis by inhibiting p300's histone acetyltransferase activity. Restoring SIK2 in tubules alleviates tubular and interstitial impairments in DKD mice, suggesting that SIK2 is a potential therapeutic target for DKD.

TRANSLATIONAL RESEARCH (2023)

Article Cell Biology

The Role of Myofibroblasts in Physiological and Pathological Tissue Repair

Ronen Schuster et al.

Summary: Myofibroblasts are crucial in wound healing by producing scar tissue, but excessive or persistent activity can lead to fibrotic diseases and organ failure. This review examines the role of myofibroblasts in tissue repair, focusing on their interaction with ECM and tissue mechanics. It also explores how mechanical intervention therapies can improve wound healing outcomes.

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2023)

Article Cell Biology

Acetyltransferase p300 regulates atrial fibroblast senescence and age-related atrial fibrosis through p53/Smad3 axis

Xiao-Yan Gao et al.

Summary: This study investigates the potential role of acetyltransferase p300 in age-related atrial fibrosis. By analyzing microarray data from atrial tissue of AF patients and SR controls, the study finds a possible relationship between p300 and cellular senescence and fibrosis. Biochemical assays and in vivo electrophysiological examination further confirm the positive effects of p300 inhibitor and knockdown on improving atrial fibrosis, reducing senescence, and decreasing AF inducibility. These findings provide new insights into AF treatment, especially for the elderly.

AGING CELL (2023)

Review Biochemistry & Molecular Biology

Targeting bromodomain-containing proteins: research advances of drug discovery

Zhaoping Pan et al.

Summary: Bromodomain (BD) is a conserved protein module found in 46 different BD-containing proteins (BCPs), which plays an important role in transcriptional regulation, chromatin remodeling, DNA damage repair, and cell proliferation. BCPs have been shown to be involved in the pathogenesis of various diseases, and researchers have developed inhibitors and degraders of BCPs to interfere with pathogenic gene transcription. This paper provides a comprehensive review of recent advances in the study of drugs that inhibit or down-regulate BCPs.

MOLECULAR BIOMEDICINE (2023)

Article Biochemistry & Molecular Biology

Therapeutic effects of selective p300 histone acetyl-transferase inhibitor on liver fibrosis

Hyunsik Kim et al.

Summary: Liver fibrosis is a result of chronic liver damage and the abnormal accumulation of extracellular matrix. A novel p300 inhibitor (A6) was validated to improve liver fibrosis in two mouse models. A6 treatment significantly reduced pathological hallmarks of liver fibrosis and gene expression of matricellular proteins. Further studies showed that A6 treatment improved liver fibrosis by destabilizing p300 protein through disruption of p300 binding to AKT. Targeting p300 with A6 has potential as a major therapeutic avenue for treating liver fibrosis.

BMB REPORTS (2023)

Review Biochemistry & Molecular Biology

Plumbagin: A Potential Candidate for Future Research and Development

Niyatee Thakor et al.

Summary: Plumbagin, a secondary metabolite from various plant families, has shown therapeutic potential in treating chronic diseases like cancer, diabetes, and malaria. However, its limited solubility, toxicity, and lack of research on human safety hinder its development as a therapeutic agent. This comprehensive review examines the toxicity, pharmacology, and safety of plumbagin, as well as the methods for isolation and quantification. It also explores the design of novel formulations to enhance its bioavailability.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2022)

Article Gastroenterology & Hepatology

Long non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex

Amaia Navarro-Corcuera et al.

Summary: This study investigated epigenetic complexes contributing to p300-mediated transcription during fibrosis, including transcription factors (TFs) and long non-coding RNAs (lncRNAs). The results demonstrated that cholangiocyte-selective p300 KO or p300 inhibition attenuate DR/fibrosis in mice, while ACTA2-AS1 regulates proliferative/fibrogenic gene expression by facilitating p300/ELK1 binding to specific promoters.

JOURNAL OF HEPATOLOGY (2022)

Review Cell Biology

Mechanical communication in fibrosis progression

Yi Long et al.

Summary: The mechanical hallmarks of fibrotic microenvironments are both outcomes and causes of fibrosis progression, presenting a significant challenge in understanding how cells sense and transmit mechanical cues. Advances in intracellular mechanotransduction pathways responding to ECM remodeling and abnormal hemodynamics have been highlighted, providing insights into potential mechano-based therapeutic targets for ameliorating fibrosis progression.

TRENDS IN CELL BIOLOGY (2022)

Review Pharmacology & Pharmacy

CRISPR-based therapeutics: current challenges and future applications

Ashley E. Modell et al.

Summary: The discovery of CRISPR-Cas systems has revolutionized therapeutic development and treatment approaches, with the ability to rapidly identify drug mechanisms, advance ex vivo therapies, and address limitations in in vivo treatments.

TRENDS IN PHARMACOLOGICAL SCIENCES (2022)

Article Oncology

EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma

Adam D. Durbin et al.

Summary: Gene expression is regulated by histone modifications, and EP300 plays a significant role in high-risk neuroblastoma. The compound JQAD1, which targets EP300, effectively induces cell apoptosis in neuroblastoma cells with limited toxicity to normal cells.

CANCER DISCOVERY (2022)

Article Oncology

Analysis and therapeutic targeting of the EP300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and Hodgkin lymphoma

Wei Wei et al.

Summary: This study reveals the distinct roles of EP300 and CREBBP in ALCL and HL, with EP300 directly modulating the expression of oncogenes and immune-related molecules. The use of EP300/CREBBP inhibitors shows strong activities against ALCL and HL cells and inhibits tumor immune escape through PD-L1.

LEUKEMIA (2022)

Article Biochemistry & Molecular Biology

Lysyl oxidase promotes renal fibrosis via accelerating collagen cross-link driving by β-arrestin/ERK/STAT3 pathway

Xiaoqin Zhang et al.

Summary: Lysyl oxidase (LOX) plays an essential role in renal fibrosis by catalyzing collagen over cross-linking. Increased LOX expression leads to deposition and cross-linking of collagen. LOX is regulated by the beta-arrestin-ERK-STAT3 pathway. Inhibition of LOX improves renal fibrosis.

FASEB JOURNAL (2022)

Article Multidisciplinary Sciences

Structural insights into p300 regulation and acetylation-dependent genome organisation

Ziad Ibrahim et al.

Summary: This article investigates how acetylation reading and writing enable the binding of the oncogenic fusion protein BRD4-NUT with the acetylase p300, resulting in self-organizing reactions that enable long-range intra- and interchromosomal interactions.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

EP300 promotes renal tubular epithelial cell fibrosis by increasing HIF2? expression in diabetic nephropathy

Yanan Gong et al.

Summary: This study found that EP300 gene is closely related to the development and progression of diabetic nephropathy (DN), and can promote the fibrotic processes of renal tubular epithelial cells by increasing the expression of HIF2 alpha.

CELLULAR SIGNALLING (2022)

Article Chemistry, Medicinal

Evaluating a Specific Dual ROCK Inhibitor against Bleomycin-Induced Idiopathic Pulmonary Fibrosis in Rats

Li Liu et al.

Summary: A study reported that compound 1, which inhibits ROCK1/2, can reduce bleomycin-induced lung fibrosis and has good drug-like characteristics.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2022)

Article Cell Biology

Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β

Alexis Paulina Jimenez-Uribe et al.

Summary: Fibrosis is characterized by pathological excessive deposition of extracellular matrix, involving a complex network of signal transduction pathways, with TGF-β playing a central role. Additionally, molecules not typically associated with fibrosis such as NOX4, mTOR, HDAC, and S1P have been found to be critical in its development.

CELLULAR SIGNALLING (2021)

Article Pharmacology & Pharmacy

Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes

Yoichi Sunagawa et al.

Summary: The study investigated the potential effects of metformin on cardiac hypertrophy by inhibiting p300-mediated acetylation of histone-H3K9 and hypertrophic responses in cardiomyocytes. Metformin was shown to suppress PE-induced and p300-mediated hypertrophic responses, suggesting its potential therapeutic use in patients with diabetes and heart failure.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2021)

Article Biochemistry & Molecular Biology

Co-condensation between transcription factor and coactivator p300 modulates transcriptional bursting kinetics

Liang Ma et al.

Summary: The coactivator p300 can dynamically coordinate its functions by forming clusters with transcription factors, enabling spatially defined activation of its catalytic activity. This co-condensation mechanism modulates the transcriptional initiation rate and burst duration of target genes, contributing to nonlinear gene regulation. The results suggest a mechanism where TF and p300 co-condensation contributes to transcriptional bursting regulation and cooperative gene control.

MOLECULAR CELL (2021)

Article Multidisciplinary Sciences

Positioning of nucleosomes containing γ-H2AX precedes active DNA demethylation and transcription initiation

Stephanie Dobersch et al.

Summary: The study demonstrates that HMGA2 induces DNA nicks during transcription initiation, promoting nucleosome incorporation containing gamma-H2AX and requiring repair-mediated DNA demethylation and transcription activation.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis

Zhong-Yi Wang et al.

Summary: This study analyzed 17,810 non-parenchymal cells from six healthy human livers, identifying potential intercellular signaling axes and master regulators involved in HSC activation during fibrogenesis. It also identified 61 liver fibrosis-associated genes that may serve as drug target candidates for NASH-related fibrosis. Regulon analysis highlighted CREB3L1 as a master regulator of many of these genes, providing insight into cell-cell interactions and master regulators underlying HSC activation in liver fibrosis.

SCIENTIFIC REPORTS (2021)

Article Gastroenterology & Hepatology

Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling

Jinhang Gao et al.

Summary: Deletion of endothelial p300 can alleviate portal hypertension and liver fibrosis caused by liver injury, reducing macrophage accumulation. The regulation of inflammation may be associated with Ccl2, NF kappa B, and BRD4.

HEPATOLOGY (2021)

Article Medicine, Research & Experimental

In vitro assessment of anti-fibrotic drug activity does not predict in vivo efficacy in murine models of Duchenne muscular dystrophy

Marine Theret et al.

Summary: The study aimed to identify potential drugs to block fibrogenic differentiation, identified 21 candidates from in vitro screening, tested 3 in vivo on DMD mice, but none significantly improved muscle pathology. It was hypothesized that the drugs tested may have adverse effects on regeneration or inflammation, leading to the lack of significant results in the treatment of fibrosis in skeletal muscle.

LIFE SCIENCES (2021)

Article Genetics & Heredity

Investigating Cellular Trajectories in the Severity of COVID-19 and Their Transcriptional Programs Using Machine Learning Approaches

Hyun-Hwan Jeong et al.

Summary: Single-cell RNA sequencing of BALF samples from COVID-19 patients allowed us to examine gene expression changes in response to SARS-CoV-2 infection. Machine learning algorithms were applied to infer cellular trajectories and identify transcriptional programs, revealing more diverse trajectories in macrophages compared to T cells. Deep-learning algorithm DrivAER identified potential drivers of transcriptomic changes for COVID-19 pathogenesis, with macrophages-related functions corresponding more to disease severity than T cells-related functions. Our findings provide a more detailed insight into the transcriptomic changes underlying the severity of COVID-19 infection.

GENES (2021)

Article Biochemistry & Molecular Biology

P300/CBP-Associated Factor Activates Cardiac Fibroblasts by SMAD2 Acetylation

Yongwoon Lim et al.

Summary: Various heart diseases lead to ineffective cardiac contraction, with cardiac fibrosis being a contributing factor. PCAF plays a key role in the activation of cardiac fibroblasts during cardiac remodeling.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Pharmacology & Pharmacy

Epigenetic regulation in fibrosis progress

Taixiong Xue et al.

Summary: Fibrosis, a common process of chronic inflammatory diseases, leads to scar formation and functional failure in organs. Epigenetic mechanisms play a crucial role in fibrosis, involving DNA methylation, histone modification, ncRNAs, and m6A modification. Targeted therapy based on epigenetics holds great potential for treating fibrosis.

PHARMACOLOGICAL RESEARCH (2021)

Review Cell Biology

Monocyte and macrophage derived myofibroblasts: Is it fate? A review of the current evidence

Megan Vierhout et al.

Summary: Research has shown the existence of macrophage-myofibroblast transition (MMT) in various systems, suggesting it could potentially occur in all fibrotic conditions and constitute a reasonable therapeutic target. Evidence supporting MMT includes co-expression of macrophage and myofibroblast markers, as well as fate-mapping experiments in murine models. Further understanding of circulating precursors and molecular mechanisms governing MMT could lead to the development of novel antifibrotic therapies.

WOUND REPAIR AND REGENERATION (2021)

Article Nutrition & Dietetics

Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats

Yoichi Sunagawa et al.

Summary: Curcumin, a p300 histone acetyltransferase (HAT) inhibitor, has been found to prevent hypertension-induced left ventricular hypertrophy (LVH) development, without affecting blood pressure and systolic function.

NUTRIENTS (2021)

Article Oncology

CBP/p300 Bromodomain Inhibitor-I-CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs

Magdalena Strachowska et al.

Summary: This study investigated the CBP/p300 bromodomain inhibitor I-CBP112, which can repress multidrug-resistance genes, enhance drug accumulation inside cells, and significantly potentiate drug effects. It was found that I-CBP112 decreased the expression of certain ABC transporters in breast, lung, and hepatic cancer cell lines, leading to increased sensitivity to a wide range of chemotherapeutics. This compound shows promise as a potent anti-multidrug-resistance agent in various cancer types.

CANCERS (2021)

Article Biochemistry & Molecular Biology

RhoA/ROCK-YAP/TAZ Axis Regulates the Fibrotic Activity in Dexamethasone-Treated Human Trabecular Meshwork Cells

Zhicheng Liu et al.

Summary: High intraocular pressure is a major risk factor for glaucoma, and abnormal fibrotic activity in human trabecular meshwork cells is considered responsible for increased resistance to aqueous humor outflow. This study used bioinformatics to identify fibrotic pathways in DEX-treated HTM cells, revealing the crucial role of RhoA/ROCK-YAP/TAZ axis in regulating fibrotic activity.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Biochemistry & Molecular Biology

Activated Histone Acetyltransferase p300/CBP-Related Signalling Pathways Mediate Up-Regulation of NADPH Oxidase, Inflammation, and Fibrosis in Diabetic Kidney

Alexandra-Gela Lazar et al.

Summary: Accumulating evidence supports the involvement of histone acetylation-based epigenetic mechanisms in the pathoetiology of diabetes-associated micro-/macrovascular complications, with a focus on diabetic kidney disease. Pharmacological inhibition of p300/CBP shows promise in down-regulating the expression of Nox subtypes, inflammation, and fibrosis in the diabetic kidney, potentially reducing the burden of DKD.

ANTIOXIDANTS (2021)

Article Cell Biology

Histone deacetylase 7 mediates endothelin-1-induced connective tissue growth factor expression in human lung fibroblasts through p300 and activator protein-1 activation

Hung-Sheng Hua et al.

Summary: The study found that ET-1 activates HDAC7 to initiate AP-1 transcriptional activity by recruiting p300 and eventually promotes the production of CTGF. HDAC7 may play a vital role in airway fibrosis and have the potential to be developed as a therapeutic target.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Article Biochemistry & Molecular Biology

Targeted degradation of the enhancer lysine acetyltransferases CBP and p300

Raghu Vannam et al.

Summary: The study presents a chemical degrader of p300/CBP, dCBP-1, designed by leveraging structures of ligand-bound p300/CBP through in silico modeling of ternary complex formation. It is exceptionally potent at killing multiple myeloma cells and can abolish the enhancer driving oncogene expression. This efficient degrader provides a useful tool for dissecting the mechanism by which these factors coordinate enhancer activity in normal and diseased cells, alongside domain inhibitors.

CELL CHEMICAL BIOLOGY (2021)

Review Cell Biology

A framework for understanding the functions of biomolecular condensates across scales

Andrew S. Lyon et al.

Summary: Biomolecular condensates are membraneless molecular assemblies formed via liquid-liquid phase separation, playing important roles in controlling biochemical reactions and regulating cell organization and function throughout eukaryotic cells.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2021)

Review Biotechnology & Applied Microbiology

Targeting metabolic dysregulation for fibrosis therapy

Xiao Zhao et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Biochemistry & Molecular Biology

Gene editing and CRISPR in the clinic: current and future perspectives

Matthew P. Hirakawa et al.

BIOSCIENCE REPORTS (2020)

Article Medicine, Research & Experimental

TGF-β-induced epigenetic deregulation of SOCS3 facilitates STAT3 signaling to promote fibrosis

Clara Dees et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Chemistry, Medicinal

Plumbagin Suppresses Pulmonary Fibrosis Via Inhibition of p300 Histone Acetyltransferase Activity

Soo Yeon Lee et al.

JOURNAL OF MEDICINAL FOOD (2020)

Article Medicine, Research & Experimental

Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice

Yan Y. Sanders et al.

JCI INSIGHT (2020)

Article Cell Biology

Differential contribution of p300 and CBP to regulatory element acetylation in mESCs

Sara Martire et al.

BMC MOLECULAR AND CELL BIOLOGY (2020)

Article Multidisciplinary Sciences

Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300

Lynn M. Williams et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Biochemistry & Molecular Biology

Biomolecular Condensates in the Nucleus

Benjamin R. Sabari et al.

TRENDS IN BIOCHEMICAL SCIENCES (2020)

Article Cardiac & Cardiovascular Systems

Histone Acetyltransferase p300 Inhibitor Improves Coronary Flow Reserve in SIRT3 (Sirtuin 3) Knockout Mice

Han Su et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)

Article Cell Biology

Acetyltransferase p300 induced cardiac fibrosis inhibitor reverses hypertension-induced cardiac fibrosis

Rahul Rai et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Article Biochemistry & Molecular Biology

Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP

Beth E. Zucconi et al.

BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

Baicalin inhibits pressure overload -induced cardiac fibrosis through regulating AMPK/TGF-P/Smads signaling pathway

Yichuan Xiao et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)

Article Biochemistry & Molecular Biology

Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome

Brian T. Weinert et al.

Article Biochemistry & Molecular Biology

The role of pro-fibrotic biomarkers in paroxysmal and persistent atrial fibrillation

Adina Elena Stanciu et al.

CYTOKINE (2018)

Article Cell Biology

Glyoxalase 1 sustains the metastatic phenotype of prostate cancer cells via EMT control

Cinzia Antognelli et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)

Review Cell Biology

Skin Cell Heterogeneity in Development, Wound Healing, and Cancer

Emanuel Rognoni et al.

TRENDS IN CELL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

The ZZ domain of p300 mediates specificity of the adjacent HAT domain for histone H3

Yi Zhang et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Article Biochemistry & Molecular Biology

A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis

Rahul Rai et al.

EPIGENETICS (2017)

Article Multidisciplinary Sciences

Epigenome-wide association studies identify DNA methylation associated with kidney function

Audrey Y. Chu et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors

Jayme L. Dahlin et al.

NATURE COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis

Elisabeth Schinner et al.

FEBS OPEN BIO (2017)

Review Pharmacology & Pharmacy

Targeting Hypoxia Inducible Factors-1α As a Novel Therapy in Fibrosis

Anji Xiong et al.

FRONTIERS IN PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Activation and overexpression of Sirt1 attenuates lung fibrosis via P300

Zhilin Zeng et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)

Article Biochemistry & Molecular Biology

Dimethyl α-ketoglutarate reduces CCl4-induced liver fibrosis through inhibition of autophagy in hepatic stellate cells

Jianjian Zhao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Review Chemistry, Multidisciplinary

Protein Lysine Acetylation by p300/CBP

Beverley M. Dancy et al.

CHEMICAL REVIEWS (2015)

Review Medicine, General & Internal

Fibrosis - A Common Pathway to Organ Injury and Failure

Don C. Rockey et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

Ariane Hammitzsch et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Chemistry, Multidisciplinary

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

Duncan A. Hay et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Article Biochemistry & Molecular Biology

Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation

Manuela Delvecchio et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)

Review Biochemistry & Molecular Biology

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

Thomas A. Wynn et al.

NATURE MEDICINE (2012)

Editorial Material Biochemistry & Molecular Biology

Scraping fibrosis

Wajahat Z. Mehal et al.

NATURE MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain Comparison With Ejection Fraction and Wall Motion Scoring

Tony Stanton et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2009)

Article Biochemistry & Molecular Biology

Inhibition of Lysine Acetyltransferase KAT3B/p300 Activity by a Naturally Occurring Hydroxynaphthoquinone, Plumbagin

Kodihalli C. Ravindra et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Multidisciplinary Sciences

CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53

Dingding Shi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Biochemistry & Molecular Biology

Regulation of the p300 HAT domain via a novel activation loop

PR Thompson et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)

Article Multidisciplinary Sciences

Polyubiquitination of p53 by a ubiquitin ligase activity of p300

SR Grossman et al.

SCIENCE (2003)